Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +48.85%
#3 Non-Playable Coin Non-Playable Coin +23.47%
#4 龙虾 (Lobster) 龙虾 (Lobster) +22.08%
#5 Pons Pons +21.99%
#6 OriginTrail OriginTrail +19.87%
#7 Zora Zora +18.45%
#8 ApeX ApeX +17.92%
#9 Morpho Morpho +17.90%
#10 UnifAI Network UnifAI Network +16.17%
Coin of the day
Smilek to the Bank Smilek to the Bank
설정
언어
한국어
통화
USD
테마
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
주식 순위 #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
주가
$2.10
마지막 동기화: 2026-08-21
시가총액
$104.43M
변동 (1일)
-2.10%
변동 (1년)
-
국가
US
거래 Polaryx Therapeutics, Inc. Common Stock (PLYX)

카테고리

Healthcare
Polaryx Therapeutics, Inc. Common Stock (PLYX)의 매출
Aug 2026 기준 매출 TTM: 0
Polaryx Therapeutics, Inc. Common Stock의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Polaryx Therapeutics, Inc. Common Stock의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH